| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Order Information | Donor Information | Biology (*1) | Phase I Activity (pmol/min/mg of protein) | Qualification (*2) | ||||||||||||||||
2 | Viable | Long | Biliary | Speher- | |||||||||||||||||
3 | Cells | Viability | Confluency | Acti- | Term | canalicili | roid for- | NPCs | |||||||||||||
4 | Lot# | Inventory | Race | Gender | Age | x106/vial | % | % | CYP1A1/2 | CYP3A4/5 | CYP2B6 | CYP2C9 | CYP2D6 | mRNA | vity(*4) | Culture(*5) | formation | DICI(*6) | mation | HCA | available |
5 | SA177 | 612 | C | F | 65 | 2-4 | 83 | 80 | TBD | TBD | TBD | TBD | TBD | ✓ | ✓ | ||||||
6 | SA164 | 426 | C | M | 56 | 6-8 | 83 | 100 | 25.1 | 15.1 | 15.8 | 24.9 | - | ✓ DR | ✓ | ||||||
7 | SA24 | 356 | A | F | 37 | 8-10 | 85 | 100 | 2.1 | 6.8 | 11.5 | 4.7 | 2.4 | ✓ DR | ✓ | ✓ | |||||
8 | SA156 | 307 | C | F | 59 | 4-6 | 89 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ DR | ✓ | ✓ | |||||
9 | BA18 | 295 | C | M | 48 | 4-6 | 80 | 90 | 2.5 | 1.1 | 10.8 | 14.9 | 1.3 | ||||||||
10 | BA166 | 293 | C | M | 45 | 2-4 | 70 | 90 | 1.1 | 2.8 | 2.3 | 8.0 | 0.4 | ✓ | ✓ | ||||||
11 | SA191 | 252 | C | M | 47 | 6-8 | 90 | 90 | TBD | TBD | TBD | TBD | TBD | ✓ DR | |||||||
12 | SA165 | 250 | C | F | 79 | 4-6 | 93 | 100 | 6.4 | 16.1 | 50.0 | 17.2 | 1.0 | ✓ DR | ✓ | ✓ | |||||
13 | SA58 | 212 | C | F | 60 | 6-8 | 80 | 90 | 11.6 | 6.6 | 14.5 | 24.2 | 5.7 | ✓ DR | |||||||
14 | SA192 | 203 | C | F | 71 | 6-8 | 91 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ DR | |||||||
15 | SA176 | 188 | C | F | 54 | 4-6 | 75 | 90 | TBD | TBD | TBD | TBD | TBD | ✓ | |||||||
16 | SA157 | 176 | C | M | 62 | 2-4 | 75 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ | ✓ | ||||||
17 | SA152 | 161 | C | M | 82 | 2-4 | 89 | 80 | 1.2 | 3.9 | 17.1 | 5.0 | 0.8 | ✓ | |||||||
18 | SA159 | 139 | C | F | 78 | 8-10 | 73 | 90 | TBD | TBD | TBD | TBD | TBD | ✓ | |||||||
19 | RA173 | 133 | C | F | 83 | 6-8 | 87 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ DR | ✓ | ✓ | |||||
20 | SA167 | 122 | C | F | 69 | 6-8 | 76 | 90 | 4.5 | 34.1 | 12.2 | 25.7 | 0.7 | ✓ DR | ✓ | ||||||
21 | SA63 | 121 | C | F | 57 | 6-8 | 90 | 100 | 29.4 | 13.6 | 33.8 | 5.8 | 5.1 | ✓ DR | ✓ DR | ✓ | |||||
22 | RA62 | 118 | AF | F | 29 | 6-8 | 85 | 90 | 4.2 | 6.1 | 23.1 | 31.5 | 4.9 | ✓ DR | |||||||
23 | RA13 | 115 | C | F | 74 | 4-6 | 80 | 90 | 0.0 | 1.1 | 0.5 | 1.9 | NA | ✓ | |||||||
24 | SA30 | 113 | C | F | 63 | 8-10 | 89 | 90 | 9.2 | 34.2 | 59.2 | 3.7 | 5.5 | ✓ DR | |||||||
25 | SA15 | 112 | C | F | 64 | 2-4 | 75 | 80 | 0.0 | 7.2 | 1.6 | 4.8 | 0.2 | ✓ | |||||||
26 | SA06 | 110 | C | M | 78 | 4-6 | 86 | 80 | TBD | TBD | TBD | TBD | TBD | ||||||||
27 | SA160 | 107 | C | F | 62 | 6-8 | 88 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ DR | ✓ | ||||||
28 | SA16 | 100 | C | F | 73 | 4-6 | 75 | 80 | 1.2 | 1.6 | 6.4 | 1.1 | 0.2 | ✓ | ✓ | ||||||
29 | SNA08 | 89 | C | M | 74 | 8-10 | 72 | 80 | 3.8 | 3.2 | 15.8 | 8.3 | 2.0 | ||||||||
30 | SA174 | 79 | C | F | 60 | 6-8 | 82 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ | ✓ | ✓ | |||||
31 | MA172 | 69 | C | M | 81 | 4-6 | 83 | 90 | 7.6 | 6.2 | 11.8 | 16.6 | 1.1 | ||||||||
32 | SA22 | 66 | C | M | 37 | 6-8 | 84 | 80 | 0.2 | 1.5 | 2.6 | 5.9 | 0.1 | ✓ | ✓ | ||||||
33 | BA23 | 64 | C | M | 33 | 14 -16 | 90 | 90 | 1.9 | 3.3 | 6.0 | 13.1 | 0.4 | ||||||||
34 | SA190 | 58 | C | F | 48 | 4-6 | 90 | 100 | TBD | TBD | TBD | TBD | TBD | ✓ | ✓ | ||||||
35 | SA158 | 56 | C | F | 54 | 2-4 | 90 | 90 | 0.9 | 17.9 | 8.8 | 7.6 | 2.1 | ||||||||
36 | SA175 | 55 | C | F | 83 | 6-8 | 80 | 100 | TBD | TBD | TBD | TBD | TBD | ||||||||
37 | SA171 | 53 | C | M | 56 | 6-8 | 81 | 90 | TBD | TBD | TBD | TBD | TBD | ✓ DR | |||||||
38 | Publishing date: July 22, 2015 |